Join Date
October 2024
Gender
Not Specified
Age
Not Specified
About Will Olsen
Co-Founder & CEO of Engage Bio
Companies & Work

Engage Bio
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine.
In 2026 Engage was acquired by Eli Lilly.
In 2026 Engage was acquired by Eli Lilly.




